• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2014 年至 2018 年期间,在加泰罗尼亚(西班牙)的一家参考中心收治的感染 RSV 的儿童中,RSV-A 细支气管炎严重程度增加。

Increased RSV-A Bronchiolitis Severity in RSV-Infected Children Admitted to a Reference Center in Catalonia (Spain) Between 2014 and 2018.

机构信息

Pediatric Hospital Medicine, Department of Pediatrics, Hospital Infantil Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Department of Pediatrics, Obstetrics and Gynecology, Preventive Medicine and Public Health, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

出版信息

J Pediatric Infect Dis Soc. 2023 Apr 18;12(3):180-183. doi: 10.1093/jpids/piad009.

DOI:10.1093/jpids/piad009
PMID:36744919
Abstract

Between 2014 and 2018, we evaluated the severity of 687 cases of bronchiolitis caused by respiratory syncytial virus (RSV) in Catalonia, Spain. Compared to RSV-B, RSV-A cases required intensive care (adjusted relative risk (aRR) = 1.44, p < 0.01) and respiratory support (aRR = 1.07, p < 0.01) more often; hospital stay was one day longer (p < 0.01). Subgroup identification may aid clinical evaluation and seasonal healthcare planning.

摘要

在 2014 年至 2018 年期间,我们评估了西班牙加泰罗尼亚地区 687 例呼吸道合胞病毒(RSV)引起的细支气管炎的严重程度。与 RSV-B 相比,RSV-A 病例更常需要重症监护(调整后的相对风险(aRR)=1.44,p<0.01)和呼吸支持(aRR=1.07,p<0.01);住院时间延长一天(p<0.01)。亚组鉴定可能有助于临床评估和季节性医疗保健计划。

相似文献

1
Increased RSV-A Bronchiolitis Severity in RSV-Infected Children Admitted to a Reference Center in Catalonia (Spain) Between 2014 and 2018.2014 年至 2018 年期间,在加泰罗尼亚(西班牙)的一家参考中心收治的感染 RSV 的儿童中,RSV-A 细支气管炎严重程度增加。
J Pediatric Infect Dis Soc. 2023 Apr 18;12(3):180-183. doi: 10.1093/jpids/piad009.
2
Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study.呼吸道合胞病毒相关儿童住院治疗:意大利回顾性观察研究。
Ital J Pediatr. 2024 Mar 7;50(1):45. doi: 10.1186/s13052-024-01617-w.
3
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒(RSV)毛细支气管炎的免疫预防作用:亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
4
Assessing the Impact of Nirsevimab Immunization on RSV Bronchiolitis Hospital Admissions and Their Severity: A Case-Control Study and Comparison With Pre- and Post-COVID-19 Seasons in a Tertiary Pediatric Hospital.评估尼塞韦单抗免疫接种对呼吸道合胞病毒细支气管炎住院率及其严重程度的影响:一项病例对照研究,并与一家三级儿科医院在新冠疫情前和后的季节进行比较。
Pediatr Pulmonol. 2025 Jul;60(7):e71059. doi: 10.1002/ppul.71059.
5
Incidence of apnea in infants hospitalized with respiratory syncytial virus bronchiolitis: a systematic review.呼吸道合胞病毒细支气管炎住院婴儿呼吸暂停的发生率:一项系统评价
J Pediatr. 2009 Nov;155(5):728-33. doi: 10.1016/j.jpeds.2009.04.063. Epub 2009 Aug 3.
6
Nirsevimab and Hospitalization for RSV Bronchiolitis.尼赛珠单抗与 RSV 毛细支气管炎住院治疗。
N Engl J Med. 2024 Jul 11;391(2):144-154. doi: 10.1056/NEJMoa2314885.
7
Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico.墨西哥儿童和成人呼吸道合胞病毒感染的流行病学及临床特征
Influenza Other Respir Viruses. 2017 Jan;11(1):48-56. doi: 10.1111/irv.12414. Epub 2016 Aug 18.
8
The burden of Respiratory Syncytial Virus (RSV) infection in the Middle East and North Africa (MENA) region across age groups: A systematic review.中东和北非(MENA)地区各年龄段人群呼吸道合胞病毒(RSV)感染负担:系统评价。
Vaccine. 2021 Jun 29;39(29):3803-3813. doi: 10.1016/j.vaccine.2021.05.076. Epub 2021 Jun 4.
9
Heliox inhalation therapy for bronchiolitis in infants.氦氧混合气吸入疗法治疗婴儿细支气管炎
Cochrane Database Syst Rev. 2015 Sep 18;2015(9):CD006915. doi: 10.1002/14651858.CD006915.pub3.
10
Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review.意大利儿科患者呼吸道合胞病毒疾病的成本及医疗保健利用情况:一项系统综述
Public Health. 2024 Feb;227:103-111. doi: 10.1016/j.puhe.2023.11.039. Epub 2023 Dec 27.

引用本文的文献

1
Genotypic Characterization of Human Respiratory Syncytial Viruses Detected in Mexico Between 2021 and 2024.2021年至2024年在墨西哥检测到的人类呼吸道合胞病毒的基因型特征
Viruses. 2025 Apr 30;17(5):651. doi: 10.3390/v17050651.
2
Respiratory Syncytial Virus Risk Profile in Hospitalized Infants and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022.2010 - 2022年西班牙巴利亚多利德住院婴儿呼吸道合胞病毒风险概况及与流感和新冠病毒对照情况比较
Infect Dis Ther. 2024 Nov;13(11):2395-2413. doi: 10.1007/s40121-024-01058-2. Epub 2024 Oct 12.
3
Molecular Epidemiology and Genetic Diversity of Human Respiratory Syncytial Virus in Sicily during Pre- and Post-COVID-19 Surveillance Seasons.
COVID-19监测前后西西里岛人类呼吸道合胞病毒的分子流行病学和遗传多样性
Pathogens. 2023 Aug 28;12(9):1099. doi: 10.3390/pathogens12091099.